Natalia N Steevens

Statistics

Publications

Citations

2.3K

H-Index

Active since

2014

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

Seattle Children's Hospital

University of Washington Medical Center

Natalia N Steevens is an author at University of Washington specializing in immunotherapy, cancer immunotherapy, and chimeric antigen receptor t-cell therapy.

Publications per year

2014–2016

Publications

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

Medicine, Immunology, Oncology +17

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Cameron J. Turtle, Carolina Berger, Daniel Sommermeyer et al. · Blood · 2015 · 70 citations

Life Sciences, Hematology, Oncology +17

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Blood · 2015 · 56 citations

Medicine, Hematology, Immunology +17

Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition

Cameron J. Turtle, Daniel Sommermeyer, Carolina Berger et al. · Blood · 2014 · 17 citations

Life Sciences, Immunology, Oncology +14

Immunotherapy with CD19-specific chimeric antigen receptor (CAR)-modified T cells of defined subset composition.

Cameron J. Turtle, Carolina Berger, Daniel Sommermeyer et al. · Journal of Clinical Oncology · 2015 · 15 citations

Life Sciences, Immunology, Oncology +15

1–5 of 5